|
|
|
Vol. 13, No. 15, pp. 1924-1935, August 1, 1999
Howard Hughes Medical Institute (HHMI), Division of Nucleic Acids Enzymology, Department of Biochemistry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854 USA; 2 Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JR, UK; 3 Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021 USA
| |
Abstract |
|---|
|
|
|---|
ATP-dependent nucleosome remodeling and core histone acetylation and deacetylation represent mechanisms to alter nucleosome structure. NuRD is a multisubunit complex containing nucleosome remodeling and histone deacetylase activities. The histone deacetylases HDAC1 and HDAC2 and the histone binding proteins RbAp48 and RbAp46 form a core complex shared between NuRD and Sin3-histone deacetylase complexes. The histone deacetylase activity of the core complex is severely compromised. A novel polypeptide highly related to the metastasis-associated protein 1, MTA2, and the methyl-CpG-binding domain-containing protein, MBD3, were found to be subunits of the NuRD complex. MTA2 modulates the enzymatic activity of the histone deacetylase core complex. MBD3 mediates the association of MTA2 with the core histone deacetylase complex. MBD3 does not directly bind methylated DNA but is highly related to MBD2, a polypeptide that binds to methylated DNA and has been reported to possess demethylase activity. MBD2 interacts with the NuRD complex and directs the complex to methylated DNA. NuRD may provide a means of gene silencing by DNA methylation.
[Key Words: DNA methylation; histone deacetylase complex; nucleosome remodeling; gene silencing]
| |
Introduction |
|---|
|
|
|---|
Packaging of DNA into chromatin allows the cell to store its
genetic information efficiently and has an important
role in regulating gene expression (Workman and Kingston 1998
). Dynamic changes in chromatin structure can facilitate or prevent the access of
the transcription machinery to nucleosomal DNA, leading to transcription regulation. Recent studies have revealed two mechanisms by which chromatin structure can be altered. One mechanism involves multisubunit protein complexes that use the energy derived from ATP
hydrolysis to alter the structure of, or `remodel', nucleosomes (for
review, see Tsukiyama and Wu 1997
; Kadonaga 1998
; Varga-Weisz and
Becker 1998
; Travers 1999
). The other mechanism involves covalent modification of nucleosomes, in particular acetylation of the core
histone tails and methylation of DNA (for review, see Grunstein 1997
;
Kuo and Allis 1998
; Struhl 1998
; Ng and Bird 1999
).
Since the discovery of histone acetylation by Allfrey et al. (1964)
, a
general correlation between histone acetylation and gene activity has
been established (Hebbes et al. 1988
). The enzymes that catalyze
histone acetylation and deacetylation have been identified (Brownell et
al. 1996
; Taunton et al. 1996
). Several transcriptional coactivators
have histone acetyltransferase (HAT) activity, whereas several
transcriptional corepressors have histone deacetylase activity (for
review, see Grunstein 1997
; Kuo and Allis 1998
; Struhl 1998
). In
addition, mutagenesis studies with Gcn5 and Rpd3, the prototypical
histone acetyltransferase and deacetylase, respectively, confirmed the
long-speculated role of histone acetylation and deacetylation in
transcription regulation (Kadosh and Struhl 1998a
; Kuo et al. 1998
;
Wang et al. 1998
). Moreover, Rpd3/Sin3-dependent
repression has been shown to be directly associated with the
deacetylation of lysine 5 of histone H4 in the promoters of
UME6-regulated genes (Kadosh and Struhl 1998b
; Rundlett et al. 1998
).
However, how core histone acetylation/deacetylation leads
to transcriptional activation/repression remains to be elucidated.
Methylation of cytosine at CpG dinucleotides is a common feature of
many higher eukaryotic genomes. Many studies have established a general
correlation between DNA methylation and gene inactivation (Razin and
Riggs 1980
). However, the underlying molecular mechanism remained
unknown until recently. It was found that MeCP2, a protein that
specifically binds to methylated DNA, copurifies with the Sin3A/HDAC corepressor complex and that the histone
deacetylase inhibitor TSA relieves MeCP2-mediated transcriptional
repression (Jones et al. 1998
; Nan et al. 1998
). Recently, four
mammalian proteins containing regions homologous to the MeCP2
methyl-CpG-binding domain, MBD1-4,
were identified by searching the expressed sequence tag (EST) databases
(Hendrich and Bird 1998
). Interestingly, MBD2 was claimed to be a DNA
demethylase, and MBD4 was shown to be an endonuclease potentially
involved in DNA mismatch repair (Bellacosa et al. 1999
; Bhattacharya et
al. 1999
). The functions of MBD1 and MBD3 are unknown.
To develop a mechanistic understanding of how core histone acetylation
regulates transcription, we have studied the histone deacetylases HDAC1
and HDAC2 (Taunton et al. 1996
; Yang et al. 1996
). Using a combination
of conventional and affinity chromatography, we previously purified and
characterized two HDAC1/HDAC2-containing histone
deacetylase complexes, the Sin3A/HDAC complex, and the NuRD complex (Zhang et al. 1997
, 1998a
,b
). The two protein complexes share four polypeptides: HDAC1, HDAC2, RbAp46, and RbAp48. In addition,
each complex contains three unique polypeptides (Sin3A, SAP30, and
SAP18 in the Sin3 complex, and Mi2, p70, and p32 in the NuRD complex).
Interestingly, the NuRD complex also possesses nucleosome remodeling
activity, most likely because of the presence of Mi2, a member of the
SWI2/SNF2 helicase/ATPase family (Tong et
al. 1998
; Xue et al. 1998
; Zhang et al. 1998a
).
To gain insight into the function of the NuRD complex, we have identified its p70 and p32 subunits. We demonstrate that these polypeptides have an important role in modulating the histone deacetylase activity of NuRD. Furthermore, we provide evidence linking NuRD function to methylated DNA.
| |
Results |
|---|
|
|
|---|
MTA2 and MBD3 are components of the NuRD complex
Previously, we reported the purification of NuRD, a multisubunit
complex containing both histone deacetylase and nucleosome remodeling
activities (Zhang et al. 1998a
). Through extensive purification using
conventional methods, combined with affinity purification using
antibodies against Mi2, the largest subunit of the complex, we
determined that this complex is composed of seven subunits, including
the SWI2/SNF2 helicase/ATPase
domain-containing Mi2 protein, the two histone deacetylases HDAC1 and
HDAC2, the two histone-binding proteins RbAp46 and RbAp48, and
polypeptides of 70 and 32 kD (Zhang et al. 1998a
). The conventionally
purified complex also contains minor contaminating polypeptides that
did not copurify with NuRD activity (Fig. 1A, lane 3; see also Fig. 3B
of Zhang et al. 1998a
).
|
We expanded our previous studies by identifying each of the
polypeptides present in the conventionally purified fraction of NuRD.
Protein sequencing of the doublet migrating around 32 kD revealed that
it corresponds to two in-frame spliced forms of MBD3, a member of a
protein family containing the methyl-CpG binding domain (Hendrich and
Bird 1998
). We named the two spliced forms MBD3a and MBD3b. The major
form in the NuRD complex is MBD3b, which only contains a portion of the
methyl-CpG binding domain (Fig. 2A,B). Interestingly,
MBD3 is highly related to MBD2 (80% similar, 72% identical; see Fig.
2A), a protein recently claimed to have DNA demethylase activity
(Bhattacharya et al. 1999
).
|
Sequencing of the 70-kD polypeptide identified it as a novel protein
highly related (65% identical) to a candidate metastasis-associated protein, MTA1. Therefore, we refer to this polypeptide as MTA2 (Fig.
2C). Interestingly, MTA1 was reported to be a component of the NURD
complex based on four peptide sequences that happen to be common
between MTA1 and MTA2 (Xue et al. 1998
). Analysis of the amino acid
sequences of MTA proteins identified one putative zinc-finger domain,
one leucine zipper domain, and a potential tyrosine kinase
phosphorylation site (Fig. 2C). The expression level of MTA1 was found
to be elevated in metastatic breast cancer cell lines and metastatic
cancer tissues, such as colorectal, gastric, and esophageal carcinomas
(Toh et al. 1994
, 1997
, 1999
). Similarly, we also found that the MTA2
expression level is elevated in cervical cancer tissue (data not
shown). However, the cause-and-effect relationship between cancer
metastasis and overexpression of MTA proteins is not known.
To further establish that MTA2 and MBD3 are integral components of the
NuRD complex, antibodies against these polypeptides were produced.
Western blot analysis using MTA2 antibodies demonstrated that MTA2
copurified with the NuRD complex and its associated nucleosome
remodeling and histone deacetylase activities (Zhang et al. 1998a
).
Affinity purification using anti-MTA2 antibodies resulted in the
isolation of a protein complex composed of seven polypeptides, all
present as major polypeptides in the conventionally purified NuRD
complex (Fig. 1A, cf. lanes 2 and 3). The identity of the polypeptides
present in the anti-MTA2 affinity purified complex was verified by
Western blot analyses as shown in Fig. 1B (lane 2). The other
polypeptides present in the conventionally purified NuRD complex (lane
3) were absent in the complex isolated through affinity chromatography
using anti-Mi2 (Zhang et al. 1998a
) or anti-MTA2 (Fig. 1A, lane 2)
antibodies. Moreover, these polypeptides did not coelute with subunits
of the NuRD complex through conventional chromatography (see Fig. 3B of
Zhang et al. 1998a
). Thus, we conclude that these polypeptides are contaminants.
Antibodies against MBD3 were capable of immunoprecipitating recombinant MBD3 protein, however, these antibodies failed to immunoprecipitate the NuRD complex (data not shown), suggesting that MBD3 is not accessible in the NuRD complex (see below).
Immunopurification experiments using antibodies against HDAC1, which should result in the isolation of most of the polypeptides associated with HDAC1, resulted in a complex pattern of polypeptides (Fig. 1A, lane 4). Comparison of the polypeptides present in this fraction with those present in the NuRD and Sin3 complexes established that most polypeptides in the anti-HDAC1 purified sample were present in the NuRD or Sin3 complex (Fig. 1A,B). Interestingly, the reported demethylase MBD2 was also present in the anti-HDAC1 purified sample (Fig. 1A,B, lanes 4; see below). In addition, we found that four polypeptides (HDAC1, HDAC2, RbAp48, RbAp46) were common to the Sin3 and NuRD complexes (Fig. 1A), whereas the other polypeptides (Sin3, SAP30, Mi2, MTA2, MBD3) were specific to one of the two complexes (Fig. 1A,B, lanes 2,5).
The studies described above establish that both MTA2 and MBD3 are integral components of the NuRD complex and suggest the existence of a shared core histone deacetylase complex composed of HDAC1, HDAC2, RbAp48, and RbAp46. These results also suggest a possible connection between the NuRD complex and methyl-CpG binding proteins.
MTA2 promotes the assembly of a catalytically active histone deacetylase complex
Having established that HDAC1, HDAC2, RbAp48, and RbAp46 are shared components of the Sin3 and NuRD complexes, we asked whether these four polypeptides can form a core protein complex. We began the studies by investigating whether a histone deacetylase core complex could be isolated from HeLa cells. These studies uncovered different complexes containing these four polypeptides (data not shown). However, we were unable to isolate a complex containing only these four polypeptides. A possible explanation is that the putative HDAC/RbAp core complex is limiting with respect to polypeptides that may associate with it.
We next asked whether an HDAC/RbAp core complex could be
reconstituted from recombinant polypeptides. In agreement with our previous studies, which demonstrated that the HDAC and RbAp association requires cotranslation and/or the presence of a molecular
chaperone (Zhang et al. 1998b
), we failed to reconstitute the core
complex using individually purified HDAC1 and HDAC2 from
baculovirus-infected SF9 cells and RbAp46 and RbAp48 purified from
Escherichia coli (data not shown). Thus, we performed coinfection
experiments using recombinant baculoviruses expressing each of the four
putative core subunits with Flag-tagged HDAC1. HDAC1 and its associated polypeptides were purified through multiple chromatographic steps, including ion exchange, immunoaffinity, gel filtration, and glycerol gradient sedimentation (Fig. 3A). Western blot
analysis demonstrated cofractionation of the four polypeptides during
each of the purification steps (data not shown). Silver staining of the
sample derived from the last purification step revealed the presence of
four major polypeptides (Fig. 3B). The identity of these polypeptides was confirmed by Western blot analysis (Fig. 3C). The contaminating protein of about 70 kD (Fig. 3B) does not react with MTA2 antibodies (Fig. 3C). These results suggest that a complex containing HDAC and
RbAp polypeptides can be formed. However, the histone deacetylase activity of this core complex was severely compromised compared to that
of native NuRD complex when equal Western blot units of HDACs or RbAps
were used (Table 1; data not shown).
|
|
We next analyzed whether the addition of the other NuRD subunits (Mi2, MTA2, and MBD3) to the core complex could restore the activity to the level of the native NuRD complex. The addition of highly purified (Fig. 3D) recombinant Mi2 and MBD3b (or MBD3a, data not shown) purified from baculovirus infected-SF9 cells, or MTA2 produced in Escherichia coli, independently or in combination, did not affect the histone deacetylase activity (Table 1, and data not shown). In light of these negative results and to determine the identity of the subunits affecting enzymatic activity, we investigated the polypeptides of the NuRD complex that interact with subunits of the core HDAC/RbAp complex.
We began the study by asking whether subunits of the putative core complex, as GST-fusion or Flag-tagged proteins, could interact with MTA2 that was translated in vitro using the rabbit reticulolysate system. We found that none of the core subunits interacted with MTA2 in this assay (Fig. 4A). However, we observed an interaction between GST-MBD3b and MTA2 under the same conditions (Fig. 4A). We extended this finding by demonstrating a direct interaction using GST-MBD3b and MTA2 produced in Escherichia coli (Fig. 4B). We next analyzed whether MBD3b interacts with components of the core complex. This analysis demonstrated that MBD3b is able to interact with highly purified (Fig. 3D) HDAC1, RbAp48, and RbAp46 in a GST pull-down assay (Fig. 4C, lanes 6,9,12). These interactions appear to be specific because MBD3b failed to interact with Mi2 under the same conditions (Fig. 4C, lane 3). The finding that MBD3 engages in multiple interactions with subunits of the core complex is consistent with the result demonstrating that antibodies against MBD3 could immunoprecipitate recombinant MBD3, but failed to immunoprecipitate the MBD3-containing NuRD complex, as discussed above. Collectively, these findings suggest that MBD3 is embedded within the NuRD complex.
|
To verify these in vitro protein-protein interaction studies, we coinfected SF9 cells with five baculoviruses each expressing one of the four core subunits and MTA2. The complex was purified as described above (Fig. 3A). In light of the protein-protein interaction results described above, we expected that during affinity purification and gel-filtration chromatography the four subunits of the core complex would copurify, but would be separated from MTA2. However, to our surprise we observed copurification of MTA2 with the core HDAC/RbAp complex during affinity purification and gel-filtration chromatography (Fig. 5; data not shown). More importantly, we found that this complex is active in deacetylating core histones (Fig. 5A; Table 1). The activity was similar (within 2.5-fold) to that of the native NuRD complex (Table 1). Our interpretation of these results is that either the association of MTA2 with the core complex requires cotranslation or, alternatively, that mammalian MTA2 can associate with the endogenous insect MBD3 that mediates the association between MTA2 and core. Silver staining (Fig. 5B) and Western blot (Fig. 5C) analyses of the fractions derived from the gel-filtration column indicate the presence of MTA2 and the HDAC/RbAp core polypeptides coeluting with HDAC activity. Moreover, the silver-staining analysis revealed polypeptides in the 30-kD range coeluting with histone deacetylase activity (Fig. 5B). Western blot analysis revealed that antibodies directed against the human MBD3 protein reacted, although weakly, with a polypeptide of ~30 kD that coeluted with the histone deacetylase activity. We concluded that the MBD3-immunoreactive 30-kD polypeptide is likely the SF9 cell-derived MBD3 (Fig. 5C). The silver-staining analysis demonstrates that the complex is highly pure and suggests that the coelution of HDACs, RbAps, MTA2, and insect-derived MBD3 is a functional association and not the result of protein aggregation.
|
To further analyze the specificity of MTA2 in directing the formation of an enzymatically active histone deacetylase complex, we performed coinfections as above, but coinfected a baculovirus-expressing MBD3 with components of the HDAC core complex in the presence and absence of MTA2. Following affinity purification, the purified complexes were divided and analyzed for histone deacetylase activity (Fig. 6A) and protein composition by western blots (Fig. 6B). As above, the core complex was severely compromised in its enzymatic activity (Fig. 6A). The presence of MBD3 was without effect. However, coinfection with MTA2 in the presence or absence of MBD3 resulted in the recovery of a complex that was enzymatically active (Fig. 6A). Consistent with our finding that MTA2 can direct the formation of an enzymatically active histone deacetylase complex, we found that infection of SF9 cells with a recombinant baculovirus-expressing Flag-tagged MTA2 followed by purification on a column containing antibodies against the Flag tag resulted in the isolation of an MTA2-containing complex that was enzymatically active (Table 1). Silver staining and Western blot analysis revealed that in addition to MTA2, polypeptides corresponding to the insect HDAC and RbAp were present in the affinity-purified sample (data not shown). Collectively, these studies demonstrate that MTA2 directs the assembly of an active histone deacetylase complex and that the association of MTA2 with the core HDAC/RbAp complex requires MBD3.
|
The NuRD complex interacts with MBD2 and is tethered to methylated DNA
The finding that MBD3 is a component of the NuRD complex suggests a
possible connection between the NuRD complex and methylated DNA.
Therefore, we investigated whether the NuRD complex could specifically
bind to methyl-CpG-containing DNA using a gel mobility-shift assay. We
found that NuRD and MBD3 failed to bind to DNA. However, under the same
conditions, MBD2 bound specifically to methylated DNA (Fig. 7A, cf.
lanes 2-6 with 15-18). This is in agreement with
previous studies (Hendrich and Bird 1998
). Moreover, because MBD3 is
likely embedded in the NuRD complex, and the major form of MBD3 present
in the complex is MBD3b, which only contains part of the
methyl-CpG-binding domain (Fig. 2A), it is not surprising that NuRD
failed to directly bind to methylated DNA.
|
Because MBD3 is highly related to MBD2 and we found that MBD3 is able
to interact with each component of the histone deacetylase core complex
(Fig. 4C), we investigated whether MBD2 associates with histone
deacetylase complexes. Immunoprecipitation experiments using antibodies
against HDAC1 resulted in the immunoprecipitation of MBD2 (Fig. 1B,
lane 4). However, as described above, MBD2 is absent from the NuRD
complex isolated through conventional (Fig. 1B, lane 3) or affinity
(Fig. 1B, lane 2) purification procedures. Nonetheless, the similarity
between MBD2 and MBD3 proteins prompted us to analyze whether MBD2
could physically interact with the NuRD complex. In this experiment,
full-length and a truncated form of MBD2 (Hendrich and Bird 1998
) were
analyzed. The repression domain of MBD1 (H-H. Ng and A. Bird, unpubl.),
a protein related to MBD2 and MBD3 through the methyl-CpG DNA-binding
domain (Hendrich and Bird 1998
), was used as a control. Different
GST-MBD fusion proteins were independently incubated with purified
NuRD complex and possible interactions were analyzed by GST pull-down
assays followed by Western blot analyses using antibodies against
different components of the NuRD complex. Whereas GST-MBD1 failed to
interact with the NuRD complex, both forms of MBD2 interacted with the NuRD complex, and the full-length form of MBD2 interacted more efficiently (Fig. 7B). Thus, we conclude that MBD2 is able to interact
directly with components of the NuRD complex.
The interaction between MBD2 and the NuRD complex prompted us to analyze whether MBD2 could tether the NuRD complex to methylated DNA. We analyzed this possibility using the gel mobility-shift assay with methylated DNA as the probe. Under these conditions, and in agreement with the studies presented above, NuRD failed to bind to DNA, but MBD2 bound to the methylated DNA specifically (Fig. 7C; data not shown). Importantly, the addition of NuRD to a DNA-binding assay containing MBD2 resulted in the production of a new DNA-protein complex that migrates slower than the MBD2-DNA protein complex. Additionally the amount of DNA in the NuRD-MBD2 ternary complex was greater than the amount of DNA in the binary MBD2-containing complex. The observed supershift is specific because addition of 3 µg of BSA (10 × the amount of NuRD used) or other proteins was without affect (data not shown). Therefore, we conclude that NuRD is tethered to methylated DNA via MBD2 and that the interaction of NuRD with MBD2 stabilizes the MBD2-DNA protein complex.
| |
Discussion |
|---|
|
|
|---|
In this study we have identified MTA2 and MBD3 as two subunits of the NuRD complex. MTA2 is related to the metastasis-associated protein MTA1, whereas MBD3 is related to MBD2, a methyl-CpG-binding domain-containing protein recently claimed to possess demethylase activity. In addition, we provide evidence that MTA2, through an interaction with MBD3, has an important role in modulating the enzymatic activity of the histone deacetylase core complex composed of HDAC1 and HDAC2 and RbAp48 and RbAp46. Furthermore, we demonstrate that the methyl-CpG binding protein MBD2 is able to tether the NuRD complex to CpG-methylated DNA.
The connection between NuRD and cellular proliferation
The nucleosome remodeling and histone deacetylase NuRD complex
contains seven subunits. In addition to the histone deacetylase core
HDAC1, HDAC2, RbAp46, and RbAp48, it contains Mi2, MTA2, and MBD3. It
is interesting to note that MTA2 is 65% identical to the
metastasis-associated protein MTA1, whose expression level was found to
be elevated in different types of cancer tissue as well as metastatic
breast cancer cell lines (Toh et al. 1994
, 1997
, 1999
). Similarly, we
found that MTA2 is highly expressed in rapidly dividing cells at both
the RNA and protein level (data not shown) indicating a correlation
between MTA2 expression and cellular proliferation. Another component
that links the NuRD complex to cellular transformation is MBD3. This
protein was initially identified because it contains a domain related
to the methyl-CpG-binding domain of MeCP2 (Hendrich and Bird 1998
).
However, in agreement with a previous report (Hendrich and Bird 1998
),
MBD3 is not able to bind to methyl-CpG specifically (Fig. 7A).
Moreover, two alternately spliced forms of MBD3 were identified. The
predominant form present in the NuRD complex is a spliced variant
deleted of the methylated CpG-binding domain. Interestingly, MBD3 is
highly related to MBD2, which was also identified as a colon cancer
antigen (Scanlan et al. 1998
). The fact that two components of the NuRD
complex are linked to malignancy, in conjunction with the fact that
patients with dermatomyositis, who produce antibodies against Mi2
(Seelig et al. 1996
), have an increased risk to malignancy (Airio et
al. 1995
), suggests a link between the NuRD complex and malignancy. Indeed the accumulative evidence strongly suggest that histone deacetylases, in particular HDAC1 and HDAC2, are associated with polypeptides that regulate cellular proliferation. The first mammalian HDAC complex to be described was Sin3, which associates with the Max-Mad heterodimer required for cellular differentiation (for review,
see Amati and Land 1994
; Pazin and Kadonaga 1997
). Additionally, Sin3
associates with the corepressor NcoR/SMRT, which
negatively regulates transcription of genes targeted by nuclear hormone
receptors and has been linked with acute promyelocytic leukemia
(Grignani et al. 1998
; Lin et al. 1998
). Furthermore, HDAC1 was found
to be associated with the tumor suppressor Rb protein (Brehm et al. 1998
; Luo et al. 1998
; Magnaghi-Jaulin et al. 1998
). Moreover, our
recent studies have uncovered that SAP30, a component of the Sin3
complex (Laherty et al. 1998
; Zhang et al. 1998b
), associates with the
Rb-binding protein RBP1 as well as with the p53-binding protein
p33ING1 (Y. Zhang and D. Reinberg unpubl.).
NuRD is targeted to methylated DNA
Since the discovery of the first nucleosome remodeling factor, the
SWI/SNF complex, about a dozen different chromatin
remodeling factors, from different organisms, have been described (for
review, see Bjorklund et al. 1999
; Travers 1999
). However, it is not
known whether these remodeling factors function on a genome-wide basis or whether they are targeted to specific genes. Genetic studies indicate that transcription of only a fraction of genes is affected by
the SWI/SNF complex (Holstege et al. 1998
), but until
recently it was not clear how the SWI/SNF complex is
recruited to promoters of SWI/SNF-regulated genes. The
first evidence suggesting that the SWI/SNF complex can be
targeted to specific genes came from studies on the human
-globin
promoter. It was demonstrated that a SWI/SNF-related
chromatin remodeling factor E-RC1 is required for the erythroid
Krüppel-like factor, ELKF, to activate transcription in vitro
using a chromatin-assembled template (Armstrong et al. 1998
). Recently,
Nasmyth and coworkers demonstrated that the SWI/SNF complex is recruited to the HO promoter by SWI5 in vivo in a cell cycle-dependent manner (Cosma et al. 1999
). Therefore, targeted nucleosome remodeling is at least one mechanism by which nucleosome remodeling complexes can function to activate transcription. Similarly, histone deacetylase complexes may also be targeted to specific promoters. For example, the histone deacetylase HDAC2 interacts with
the transcription factor YY1, and thus could be recruited to promoters
containing YY1-binding sites (Yang et al. 1996
). Moreover, the
Sin3/HDAC complex can be recruited by Mad-Max, Ume6, and
unliganded nuclear hormone receptors to specific promoters (for review,
see Pazin and Kadonaga 1997
). Additionally, the Sin3-histone deacetylase complex can also be recruited via the methyl-CpG binding protein MeCP2 to methylated regions of the genome (Jones et al. 1998
;
Nan et al. 1998
). Therefore, targeted deacetylation represents at least
one mechanism by which histone deacetylase complexes can be recruited.
Previously, we and others have shown that the NuRD complex has both
nucleosome-remodeling and histone deacetylase activities (Tong et al.
1998
; Xue et al. 1998
; Zhang et al. 1998a
). It was also shown that
recruitment of the NuRD complex to a promoter results in transcription
repression (Kehle et al. 1998
; Xue et al. 1998
). We proposed that the
NuRD complex is targeted to specific genes by transcription factors
(Zhang et al. 1998a
).The NuRD-subunit MTA2 contains a zinc-finger
(CX2CX17CX2C) belonging to the type found
in transcription factors that bind to the GATA sequence involved in
hematopoiesis and heart development (Orkin 1992
; Lyons 1996
). These
observations prompted us to analyze whether MTA2 or the NuRD complex
could bind to the human
-globin gene promoter using the gel
mobility-shift assay. This assay failed to detect any DNA binding
activity (data not shown). This negative result can be explained
because several amino acids involved in GATA sequence recognition are
not conserved in the MTA2 zinc-finger domain (Omichinski et al. 1993
).
Similar to previous studies demonstrating that Mad, a protein that
interacts with the Sin3-histone deacetylase corepressor complex, but
is not an integral component of the complex, can recruit the
corepressor complex to specific promoters (for review, see Pazin and
Kadonaga 1997
), we found that the methyl-CpG binding protein MBD2,
although not an integral component of the NuRD complex (Fig. 1B), has
the ability to directly interact with the NuRD complex and recruit it
to methylated DNA (Fig. 7). The implication of this result is that the
NuRD complex may play a role in methylation-associated gene silencing.
In support of this hypothesis are recent findings demonstrating that
artificial recruitment of MBD2 to promoters results in repression of
transcription, which was reversed by the histone deacetylase inhibitor
Trichostatin A (Ng et al. 1999
). All of the evidence discussed above
suggests that MBD2 functions as a transcriptional repressor. However,
it is worth noting that MBD2 was recently reported to have demethylase
activity (Bhattacharya et al. 1999
). Because DNA methylation causes
gene silencing, a demethylase is likely to function as a
transcriptional activator. It remains to be determined how MBD2
activity can be converted from a repressor to an activator. Given the
similarity between MBD2 and MBD3 (72% identical), we tested the
recombinant MBD3 protein (produced in Escherichia coli or SF9
cells) and the native NuRD complex for demethylase activity and failed
to detect such an activity (data not shown).
Can NuRD also be recruited to promoters by gene-specific DNA-binding
protein? It has been shown that the Drosophila gap gene hunchback can interact with Drosophila Mi2 and
potentially recruit the NuRD complex to repress
hunchback-regulated HOX genes (Kehle et al. 1998
). Recently,
it was also reported that Ikaros, a zinc finger DNA-binding protein
essential for lymphocyte lineage determination, through interaction
with Mi2, recruits the NuRD complex to heterochromatin regions (Kim et
al. 1999
). It is therefore likely that DNA-binding proteins, which in
principle have a restricted specificity as compared to MBD2, can also
target the NuRD complex to specific genes. The interplay between
sequence-specific DNA-binding proteins and MBD2 in recruiting the NuRD
complex to specific genes may represent another pathway for regulation
of the NuRD complex.
The function of the NuRD complex
The NuRD complex was purified based on its histone deacetylase and
nucleosome remodeling activities (Tong et al. 1998
; Xue et al. 1998
;
Zhang et al. 1998a
). The biochemical association of the histone
deacetylase and nucleosome remodeling activities suggest that these two
enzymatic activities are functionally related. It is conceivable that
nucleosome remodeling may be required for nucleosomal histone
deacetylation in vivo. Therefore, the presence of these two activities
in one protein complex may represent an efficient way to facilitate
dynamic changes in nucleosome structure. Based on the finding that a
similar protein complex is also present in Xenopus eggs (Wade
et al. 1998
), we believe that the function of the NuRD complex is
rather general. Several reports have already shed light on its
potential biological function. Studies in Drosophila implicated NuRD in repression of homeotic (HOX) genes and
Polycomb-group genes (Kehle et al. 1998
). In addition, NuRD has been
shown to be associated with the zinc-finger DNA-binding protein Ikaros in toroidal structures presumed to be associated with centromeric heterochromatin in the G1 and S phase of the T-lymphocyte
cell cycle (Brown et al. 1997
; Kim et al. 1999
). This suggests that NuRD is involved in centromeric silencing, consistent with the requirement of histone deacetylase activity for the maintenance of the
underacetylated state of centromeric histones (Ekwall et al. 1997
). It
is interesting to note that Ikaros is required for the differentiation
of all three lymphoid lineage (Georgopoulos et al. 1994
). Because
Ikaros can recruit NuRD, it is possible that NuRD may play an important
role in lymphocyte development. We provide evidence indicating that
NuRD is potentially involved in transcriptional repression of
methyl-CpG through an interaction with the methyl-CpG-binding protein
MBD2. Therefore, the two best-characterized histone deacetylase
complexes, Sin3 and NuRD, are both involved in transcriptional
repression of methylated DNA. MBD2 was recently shown to be a component
of the MeCP1 complex (Meehan et al. 1989
; Ng et al. 1999
). Because
MeCP2 binds methylated DNA much tighter than MeCP1 (Meehan et al. 1989
;
Lewis et al. 1992
), it is possible that the Sin3/HDAC
complex may be involved in long-term silencing of methylated DNA
sequences, whereas the NuRD complex may be involved in transient
silencing of some methylated genes.
To maintain epigenetic silencing of genes through multiple cell
divisions, newly deposited histones that are acetylated in the
cytoplasm must be deacetylated (Jeppesen 1997
). The identity of the
histone deacetylase complex responsible for this function is unknown.
It is intriguing that Ikaros forms a higher-order toroidal structure
with NuRD that colocalizes with components of the DNA replication
machinery upon T-cell activation (Avitahl et al. 1999
; Kim et al.
1999
). Therefore, the nucleosome-remodeling and histone deacetylase
activities of the NuRD complex are ideal candidates for deacetylating
the deposition-related acetylated lysine residues during chromatin maturation.
| |
Materials and methods |
|---|
|
|
|---|
Purification of the NuRD complex and cloning of MTA2 and MBD3
The procedure for conventional purification of the NuRD complex has
been described (Zhang et al. 1998a
). The purified NuRD complex derived
from Mono S column was concentrated using a centricon concentrator and
was resolved on a 10% SDS-polyacrylamide gel. After Coomassie blue
staining, protein bands were excised and subjected to in-gel tryptic
digestion. The previously identified polypeptides were verified by
mass-spectrometric analysis (Erdjument-Bromage et al. 1998
; Geromanos
et al. 1998
). Protein bands corresponding to p70 and p32 were sequenced
as described (Zhang et al. 1997
). The peptide sequences obtained were
used to search the EST database. Multiple EST clones were identified
and were used to construct the full-length cDNA clones encoding p70 and
p32. Clones encoding alternative spliced forms of p32 (MBD3a and MBD3b)
were identified in human and mouse by sequencing EST clones (see text).
Affinity purification using anti-MTA2, anti-HDAC1, and anti-SAP30 was
based on a previously published procedure (Zhang et al. 1998b
) using HeLa nuclear extracts fractionated on phosphocellulose and DEAE-52 columns.
Baculoviruses, recombinant core complex, and antibodies
Baculoviruses expressing RbAp46, RbAp48, and HDAC1 have been
described (Hassig et al. 1997
; Verreault et al. 1998
).
Baculovirus-expressing HDAC2 was constructed using the pFastBac HTb
vector (GIBCO BRL) and was a gift from Dr. Ed Seto (Moffitt Cancer
Center, Tampa, FL). cDNAs encoding His-tagged Mi2 and MBD3 and
Flag-tagged MTA2 were constructed using the pVL1392 vector and the
recombinant viruses were generated using BaculoGold DNA (Pharmigen).
Histone deacetylase core complex and core plus MTA2 were purified using the procedure shown in Figure 3A. Extracts derived from SF9-infected cells (11 grams) were loaded onto a 35-ml DEAE-cellulose column and
were eluted with six column volumes using a linear gradient of buffer C
(20 mM Tris-HCl at pH 7.9, 0.2 mM EDTA, 10 mM
-ME, 0.2 mM PMSF, 10% glycerol) from 50 mM to 400 mM of KCl (BC50-BC400). The fractions
containing the peak of the recombinant core complex (160-269
mM KCl) were pooled and incubated with 0.5 ml of anti-Flag M2
affinity gel (Eastman Kodak) at 4°C for 2 hr. Proteins were eluted
with 0.5 ml of BC400 containing 0.1 mg of Flag peptide. The affinity
purified core complex was further purified through a gel filtration
Sephadex-200 (10/30) column. The complex eluted with an
apparent mass of ~450 kD. Finally, the core complex was purified by
sedimentation through a 15%-50% glycerol gradient. Recombinant
HDAC1-Flag and MBD3-His proteins were purified using anti-Flag M2
affinity gel (Eastman Kodak) and Ni2+-NTA agarose (Qiagen),
respectively. Recombinant RbAp48 and RbAp46 were generated by cleaving
the GST fusion proteins produced in Escherichia coli with
thrombin. Antibodies against Mi2, Sin3, HDAC1, HDAC2, RbAp48, RbAp46,
SAP30, and MBD2 were described previously (Zhang et al. 1998a
; Ng et
al. 1999
). Antibodies against MTA2 and MBD3 were generated by injecting
recombinant proteins into rabbits.
Histone deacetylase assays
Core histone octamers were purified from HeLa cells as described
(Zhang et al. 1998b
) and acetylated with yeast Hat1p in buffer containing 50 mM HEPES (pH 7.8), 50 mM KCl, 0.1 mM
EDTA, 1 mM DTT, 1 mM PMSF, 10 mM sodium
butyrate, 10% glycerol, 5 µM [3H]-acetyl
coenzyme A, and 0.5 mg/ml core histones. Acetylated core
histones were purified on a phosphocellulose column. Histone deacetylase assays were performed as described (Zhang et al. 1998b
) with 1 µg of labeled core histones.
Gel mobility shift assays
Gel mobility-shift assays were performed with modifications from a
published procedure (Meehan et al. 1989
; Nan et al. 1993
). Data
presented in Figure 7A used GAM6 probe and the binding reactions were
carried out in 20 mM HEPES buffer at pH 7.9, 1 mM
EDTA, 3 mM MgCl2, 10 mM
2-mercaptoethanol, 4% glycerol, 0.1% Triton X-100, and 500 ng of poly
[d(G-C)] at 25°C for 30 min. Each reaction contains 0.1 ng of
probe and 10-80 ng of recombinant MBDs or 50-300 ng of the NuRD
complex. The reactions were loaded onto a 2% agarose gel and resolved
with 0.5× TBE containing 5 mM magnesium acetate and 3%
glycerol. The supershift assay shown in Figure 7C used the MeCG11 probe
in a reaction similar to the above except it also contained 100 mM NaCl, 0.1 mg/ml BSA, and 300 ng of
Escherichia coli DNA as competitor. Approximately 200 ng of
GST-MBD2a and 300 ng of NuRD were used. Reactions were incubated on
ice for 2 hr before electrophoresis on a 1% agarose gel.
GST pull-down assays
Approximately 2-3 µg of GST fusion proteins were bound to glutathione-Sepharose beads and incubated with in vitro translated, or purified recombinant proteins, or purified NuRD complex at 4°C for at least 4 hr. Beads were then washed three times with buffer containing 300 mM KCl and 0.05% NP40 for three times before loading onto SDS-PAGE. The bound proteins were revealed by fluorography or Western blot analysis.
| |
Acknowledgments |
|---|
We are grateful to Drs. E. Seto and S.C. Tsai for baculovirus expressing HDAC2, to S. Schreiber for baculovirus expressing HDAC1, to A. Verreault and B. Stillman for baculoviruses expressing RbAp46 and RbAp48, and to D. Gottschling for the plasmid encoding yeast Hat 1. We thank Dr. George Orphanides for critical reading of the manuscript. We also thank members of the Reinberg laboratory for stimulating discussions during the course of this work. Y.Z. is a recipient of a National Institutes of Health (NIH) fellowship (1F32GM19515-01). H.H.N. holds a Darwin Trust Scholarship. D.R. is supported by a grant from NIH (GM-48518) and from the HHMI. A.B. is supported by grants from the Wellcome Trust. P.T. is supported by grants from the National Science Foundation and the National Cancer Institute.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked `advertisement' in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received May 26, 1999; revised version accepted June 23, 1999.
1 Present address: Lineberger Comprehensive Cancer Center, Deptartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295 USA.
4 Corresponding author.
E-MAIL reinbedf{at}umdnj.edu; FAX (732) 235-5294.
| |
References |
|---|
|
|
|---|